Clinical Resources

Neurodegeneration with Brain Iron Accumulation

On Demand

60 Minutes

Foundational / Beginner

1121<span style="line-height:115%;">This course aims to provide you with a structured understanding of the approach and management of neurodegeneration with brain iron accumulation. Upon completion of this course, you will be able to discuss different types of neurodegeneration with brain iron accumulations, including age of onset, clinical manifestations, and genetics; differential diagnosis of neurodegeneration with brain iron accumulations and approach to diagnosis including imaging; as well as review treatment approaches in neurodegeneration with brain iron accumulations.</span>Biomarkers, Biomarkers & Diagnostic Tools, Cognitive impairment/Dementia, Genetic & Hereditary Disorders, Genetics, Medications for motor symptoms, Neuroimaging, Neuropathology, Non-motor Symptoms/Disorders, Other Movement Disorders, Physical Therapy/Physiotherapy, Rating Scales, Sensory disorders, Speech Disorders, Therapies-Other, Therapies-PharmacologicalSusanne Schneider, MD, Soaham Desai, MD, DM601.00https://education.movementdisorders.org/Detail/1121/Neurodegeneration-with-Brain-Iron-Accumulationhttps://education.movementdisorders.org/Upload/ActivityImages/05INTERACT-47-001-Neurodegeneration-with-Brain-Iron-Accumulation--202x108626849.jpghttps://education.movementdisorders.org/Upload/BannerImages/05INTERACT-47-001-Neurodegeneration-with-Brain-Iron-Accumulation-734x404812281.jpg2026-08-21T00:00:002029-08-21T00:00:00<p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available<a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Final%20Disclosure%20Block_Neurodegeneration%20with%20Brain%20Iron%20Accumulation_14072026110011.pdf" rel="noopener noreferrer" target="_blank">&nbsp;HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION&nbsp;</strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p><span style="background-color: null;">Susanne A. Schneider, MD - University Medical Center of the Johannes, Gutenberg University - Mainz, Germany</span></p><p><span style="background-color: null;">Soaham Desai, MD, DM - Shree Krishna Hospital, Pramukhswami Medical College, Bhaikaka University, Karamsad - Anand, Gujarat, India</span></p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:&nbsp;</p><p>1. Discuss different types of NBIA, including age of onset. clinical manifestations, and genetics</p><p>2. Discuss the differential diagnosis of NBIAs and approach to diagnosis, including imaging.</p><p>3. Review treatment approaches in NBIAs.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Neurodegeneration-with-Brain-Iron-Accumulation.htmNeurodegeneration with Brain Iron Accumulation2026-08-21T00:01:01.72000Foundational / BeginnerOn-DemandBiomarkers &amp; Diagnostic ToolsNon-motor Symptoms/DisordersOther Movement DisordersTherapies-OtherTherapies-Pharmacological

Journal CME 41.08: Metabolic and Volumetric Alterations in the Basal Ganglia and the Cerebellum in Dopa-Responsive Dystonia in Symptomatic and Asymptomatic GCH1 Mutation Carriers

On Demand

60 Minutes

Experienced / Intermediate

1147<p>The Journal CME 41.08 article aims to characterize the volumetric and neurometabolic brain changes in GCH1 mutation carriers (MC) and explore their relationship with clinical severity.</p>Basal Ganglia, Biomarkers, Biomarkers & Diagnostic Tools, Dystonia, Etiology & Pathophysiology, Genetics, Hyperkinetic Movement Disorders, Neuroimaging, Neuropathology, Rating ScalesJannik Prasuhn, MD601.00https://education.movementdisorders.org/Detail/1147/Journal-CME-41-08:-Metabolic-and-Volumetric-Alterations-in-the-Basal-Ganglia-and-the-Cerebellum-in-Dopa-Responsive-Dystonia-in-Symptomatic-and-Asymptomatic-GCH1-Mutation-Carriershttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2026-08-14T00:00:002027-08-14T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.08%20-%20Disclosures_12082026085638.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the role of GCH1 and tetrahydrobiopterin in dopamine synthesis</p><p>2. Assess the clinical and imaging methods used to characterize GCH1-related DRD</p><p>3. Evaluate structural and metabolic changes in the basal ganglia and cerebellum associated with GCH1-related DRD</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Journal-CME-41.08-Metabolic-and-Volumetric-Alterations-in-the-Basal-Ganglia-and-the-Cerebellum-in-Dopa-Responsive-Dystonia-in-Symptomatic-and-Asymptomatic-GCH1-Mutation-Carriers.htmJournal CME 41.08: Metabolic and Volumetric Alterations in the Basal Ganglia and the Cerebellum in Dopa-Responsive Dystonia in Symptomatic and Asymptomatic GCH1 Mutation CarriersJournal CME 41.082026-08-14T18:00:53.07700Experienced / IntermediateOn-DemandBiomarkers &amp; Diagnostic ToolsEtiology &amp; PathophysiologyHyperkinetic Movement Disorders

Trastornos Integrales del Movimiento: De la Ciencia Traslacional a la Práctica Clínica - Presentado en Español

In-Person

Santiago

Dec 09, 2026 - Dec 12, 2026

Experienced / Intermediate, Foundational / Beginner

1142<p><em>&nbsp;</em></p>"<em>MDS-PAS: Curso integral sobre trastornos del movimiento: de la ciencia traslacional a la pr&aacute;ctica cl&iacute;nica &ndash; Presentado en espa&ntilde;ol</em>" es un programa educativo de cuatro d&iacute;as que combina dos cursos complementarios en una experiencia de aprendizaje &uacute;nica e integrada. El programa comienza sentando las bases de la ciencia traslacional y explorando los avances cient&iacute;ficos y los principios de investigaci&oacute;n que impulsan la innovaci&oacute;n en el campo de los trastornos del movimiento. Posteriormente, se centra en una revisi&oacute;n cl&iacute;nica exhaustiva de los principales trastornos del movimiento, haciendo hincapi&eacute; en el razonamiento diagn&oacute;stico, el manejo basado en la evidencia, el an&aacute;lisis interactivo de casos y los talleres pr&aacute;cticos. Al integrar estas perspectivas complementarias, el curso tiende un puente entre el descubrimiento cient&iacute;fico y la pr&aacute;ctica cl&iacute;nica, al tiempo que fortalece la experiencia regional, fomenta la colaboraci&oacute;n multidisciplinaria y promueve el establecimiento de redes profesionales en toda Am&eacute;rica Latina y en la comunidad global de la MDS.<br /><br /><strong>FECHA L&Iacute;MITE DE INSCRIPCI&Oacute;N: </strong>8 de diciembre de 2026<p><strong>&nbsp;</strong></p>Animal models, Autoimmune, Basal Ganglia, Basic/Translational Neuroscience, Biomarkers, Biomarkers & Diagnostic Tools, Chorea/Huntingtons Disease (HD), Corticobasal Syndrome (CBS)/Corticobasal Degeneration (CBD), Dystonia, Freezing of Gait (FOG), Gene Therapies, Genetics, Hyperkinetic Movement Disorders, Lewy-body dementia (LBD), Microbiome, Multiple Systems Atrophy (MSA), Myoclonus, Neuroimaging, Neuropathology, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Progressive Supranuclear Palsy (PSP), Rating Scales, Synucleinopathy, Tauopathy, Tics/Tourettes syndrome (TS), Tremor/Essential Tremor (ET)16500.00https://education.movementdisorders.org/Detail/1142/MDS-PAS-Trastornos-Integrales-del-Movimiento:-De-la-Ciencia-Traslacional-a-la-Práctica-Clínica---Presentado-en-Español-https://education.movementdisorders.org/Upload/ActivityImages/26PASBASIC_202x10826235.png2026-12-09T00:00:002026-12-12T00:00:00SantiagoMDS Education<p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26PASMD%20Course%20Schedule%20-%20NO%20FACULTY_07082026093217.pdf" rel="noopener noreferrer" target="_blank"><img width="87" height="87" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1786042837676_06082026020038.png" alt="A simple red calendar icon with a grid layout, featuring two hooks at the top." class="fr-fic fr-dii"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26PASMD%20Course%20Schedule%20-%20NO%20FACULTY_07082026093217.pdf" rel="noopener noreferrer" target="_blank"><strong>Horario del curso</strong></a><strong>&nbsp;</strong><a href="https://form.jotform.com/262175930145153" rel="noopener noreferrer" target="_blank"><img width="112" height="112" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1786042837627_06082026020037.png" alt="A red dollar bill with wings, symbolizing money in flight or financial freedom." class="fr-fic fr-dii"></a><a href="https://form.jotform.com/262175930145153" rel="noopener noreferrer" target="_blank"><strong>Subvenci&oacute;n de viaje</strong></a><strong>&nbsp;</strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty%20Listing%20TBD_07082026092331.pdf" rel="noopener noreferrer" target="_blank"><img width="98" height="98" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1786042837703_06082026020038.png" alt="A simple red icon depicting a person standing behind a podium." class="fr-fic fr-dii"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty%20Listing%20TBD_07082026092331.pdf" rel="noopener noreferrer" target="_blank"><strong>Profesorado del curso</strong></a></p><p><br></p><p><em>Calendario al 8 de agosto de 2026</em></p><p><em>Fecha l&iacute;mite para la subvenci&oacute;n de viaje: 30 de octubre de 2026</em></p><p><u><strong><br></strong></u></p><p><strong>CUOTAS DE INSCRIPCI&Oacute;N</strong></p><p><strong>Miembros:</strong>&nbsp;$200 USD</p><p><strong>Miembros (Junior / HP / Ciencias B&aacute;sicas / Sin cuota):</strong>&nbsp;$100 USD</p><p><strong>No miembros*:&nbsp;</strong>$350 USD</p><p>*Los no miembros que deseen solicitar la afiliaci&oacute;n a la MDS para beneficiarse de la tarifa de miembro en este curso deber&aacute;n tramitar su solicitud a m&aacute;s tardar dos semanas antes del cierre de las inscripciones.</p><p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/VISA%20STATEMENT%20CANCELLATION%20LANGUAGE_07082026093517.pdf" rel="noopener noreferrer" target="_blank">Haga clic aqu&iacute; para ver la pol&iacute;tica de cancelaci&oacute;n de cursos regionales de MDS y la informaci&oacute;n sobre asistencia para visas.</a></p><p><br></p><p><strong>LUGAR DEL CURSO</strong></p><p>Cl&iacute;nica Universidad de los Andes</p><p>Av Plaza 2501, Las Condes, Regi&oacute;n Metropolitana</p><p>Santiago, Chile</p><p><br></p><p><strong>OBJETIVOS DE APRENDIZAJE</strong></p><p>Al finalizar esta actividad, los participantes ser&aacute;n capaces de:</p><p>&nbsp;</p><p>1. Explicar las bases moleculares y los mecanismos fisiopatol&oacute;gicos subyacentes a los s&iacute;ndromes parkinsonianos, la diston&iacute;a, la ataxia, la corea y otros trastornos del movimiento.</p><p>2. Interpretar biomarcadores y modelos relevantes para los trastornos del movimiento, incluyendo neuroimagen, biomarcadores en fluidos, escalas cl&iacute;nicas, modelos animales, modelos celulares y herramientas gen&oacute;micas.</p><p>3. Aplicar principios gen&oacute;micos pr&aacute;cticos al abordaje cl&iacute;nico de los trastornos del movimiento, incluyendo el an&aacute;lisis de pedigr&iacute;, la interpretaci&oacute;n de variantes, el asesoramiento gen&eacute;tico y la toma de decisiones basada en casos cl&iacute;nicos.</p><p>4. Reconocer y clasificar los trastornos del movimiento hipocin&eacute;ticos e hipercin&eacute;ticos mediante la fenomenolog&iacute;a cl&iacute;nica y el an&aacute;lisis basado en video.</p><p>5. Desarrollar planes de manejo basados en la evidencia para la enfermedad de Parkinson, el parkinsonismo at&iacute;pico, la diston&iacute;a, la corea, la enfermedad de Huntington, la ataxia, los tics, las mioclon&iacute;as, los trastornos del movimiento inducidos por f&aacute;rmacos, los trastornos autoinmunes, las urgencias, los trastornos funcionales del movimiento y los trastornos del movimiento en pediatr&iacute;a.</p><p>6. Identificar candidatos adecuados para terapias avanzadas, incluyendo toxina botul&iacute;nica, estimulaci&oacute;n cerebral profunda, terapias asistidas por dispositivos, terapias basadas en genes o ARN y atenci&oacute;n multidisciplinaria.</p><p><br></p><p><strong>P&Uacute;BLICO OBJETIVO</strong></p><p>Esta actividad est&aacute; dirigida a m&eacute;dicos cl&iacute;nicos, especialistas en trastornos del movimiento, m&eacute;dicos en formaci&oacute;n de subespecialidad (*fellows*), personal de enfermer&iacute;a y otros profesionales de la salud.</p>Santiago0/Courses/Trastornos-Integrales-del-Movimiento-De-la-Ciencia-Traslacional-a-la-Prctica-Clnica---Presentado-en-Espaol.htmTrastornos Integrales del Movimiento: De la Ciencia Traslacional a la Práctica Clínica - Presentado en Español2026-08-11T12:00:56.47700Experienced / IntermediateFoundational / BeginnerIn-PersonBasic/Translational NeuroscienceBiomarkers &amp; Diagnostic ToolsHyperkinetic Movement DisordersParkinson Disease/Hypokinetic Movement Disorders

Hyperkinetic and Hypokinetic Movement Disorders Course for Neurologists

In-Person

Addis Ababa

Nov 18, 2026 - Nov 19, 2026

Foundational / Beginner

1141<p>This MDS-AS Hyperkinetic and Hypokinetic Movement Disorders Course for Neurologists will cover both hyperkinetic disorders&mdash;including tremor, dystonia, chorea, and paroxysmal movement disorders&mdash;and hypokinetic disorders, with a major focus on Parkinson&rsquo;s disease and Parkinsonian syndromes. Through expert-led lectures, case-based discussions, and practical clinical sessions, participants will learn contemporary approaches to differential diagnosis, use of diagnostic tools, pharmacologic and non-pharmacologic treatments, and long-term patient management. The course will also address challenges unique to resource-constrained settings and highlight strategies for improving movement disorder care in Africa.</p><p>&nbsp;</p><p><strong></strong><strong><span style="color:#990000;">APPLICATION DEADLINE</span></strong><span style="color:#990000;">:</span>&nbsp;September 8, 2026</p>Anxiety/Depression, Autonomic Dysfunction, Botulinum toxin, Chorea/Huntingtons Disease (HD), Clinical Trials, Cognitive impairment/Dementia, Complementary and Alternative Medicine, Corticobasal Syndrome (CBS)/Corticobasal Degeneration (CBD), Dopaminergic medications, Dystonia, Exercise, Freezing of Gait (FOG), Hyperkinetic Movement Disorders, Impulse Control Disorders, Infusion therapy, Lewy-body dementia (LBD), Medications for motor complications, Medications for motor symptoms, Medications for non-motor symptoms, Multiple Systems Atrophy (MSA), Myoclonus, Neuropsychiatric symptoms, Non-motor Symptoms/Disorders, Nutritional Therapy, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Progressive Supranuclear Palsy (PSP), Psychosis, Sensory disorders, Sleep Disorders, Speech Disorders, Therapies-Other, Therapies-Pharmacological, Tics/Tourettes syndrome (TS), Tremor/Essential Tremor (ET)6180.00https://education.movementdisorders.org/Detail/1141/MDS-AS-Hyperkinetic-and-Hypokinetic-Movement-Disorders-Course-for-Neurologistshttps://education.movementdisorders.org/Upload/ActivityImages/26AFRMOVE_202x108291642.png2026-11-18T00:00:002026-11-19T00:00:00Addis Ababa<p><br></p><p><br></p>MDS Education<p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/LMS%20Course%20Schedule_04082026095038.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Course schedule_23012024043738.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/LMS%20Course%20Schedule_04082026095038.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Schedule</strong></a><strong>&nbsp; &nbsp;&nbsp;</strong><strong>&nbsp; &nbsp; <a href="https://form.jotform.com/250635497536163" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Travel assistance_23012024043912.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a></strong><a href="https://form.jotform.com/262165449416158" rel="noopener noreferrer" target="_blank"><strong>Travel Bursary</strong></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/LMS%20Faculty%20Listing_04082026102054.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Faculty Details_23012024043924.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/LMS%20Faculty%20Listing_04082026102054.pdf" rel="noopener noreferrer" target="_blank"><strong>Course Faculty</strong></a></p><p><em>Schedule as of &nbsp;August 4, 2026</em></p><p><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members:</strong>&nbsp;$20 USD</p><p><strong>Non-Members:</strong>&nbsp;$150</p><p>*<em>Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.</em></p><p><a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/VISA%20STATEMENT%20CANCELLATION%20LANGUAGE_24012024041714.pdf">Click here to view the MDS Regional Course Cancellation Policy &amp; Visa Assistance Information</a></p><p><br><strong>SCHEDULE OVERVIEW</strong><br>Day 1: Wednesday, November 18, 2026 from 13:00 - 19:00<br>Day 2: Thursday, November 19, 2026 from 08:30 - 19:00<br><br><span style="background-color: null;"><strong>COURSE VENUE</strong></span></p><p>Elilly International Hotel</p><p>Addis Ababa, Ethiopia</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Recognize and differentiate common hyperkinetic and hypokinetic movement disorders based on clinical phenomenology</p><p>2. Distinguish Parkinson&rsquo;s disease from atypical and secondary parkinsonian syndromes</p><p>3. Develop evidence-based diagnostic and treatment approaches for patients presenting with movement disorders</p><p>4. Apply practical approaches to movement disorder management in resource-constrained settings</p><p>5. Collaborate effectively within multidisciplinary teams to provide comprehensive movement disorder care</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is designed for neurologists seeking to strengthen their knowledge and clinical skills in the diagnosis and management of movement disorders.</p>Addis Ababa0/Courses/Hyperkinetic-and-Hypokinetic-Movement-Disorders-Course-for-Neurologists.htmHyperkinetic and Hypokinetic Movement Disorders Course for Neurologists2026-08-11T12:00:53.88000Foundational / BeginnerIn-PersonHyperkinetic Movement DisordersNon-motor Symptoms/DisordersParkinson Disease/Hypokinetic Movement DisordersTherapies-OtherTherapies-Pharmacological